Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05240105
Other study ID # EPPIK
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 11, 2021
Est. completion date December 31, 2023

Study information

Verified date February 2022
Source University Hospital Heidelberg
Contact Simone U Jennissen, PhD
Phone 004962215634620
Email simone.jennissen@med.uni-heidelberg.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to evaluate the so-called platform model and its suitability to determine staffing in hospitals for psychosomatic medicine and psychotherapy.


Description:

The aim of the study is to test the suitability of a structural model (so-called platform model) developed by a working group of various scientific societies and professional associations for staffing in psychosomatic medicine and psychotherapy. For this purpose, in three steps (1.) the four treatment clusters developed in the platform model will be quantified and empirically validated on the basis of the therapeutic services provided in health care practice; (2.) the current staffing for the four treatment clusters will be described ("as-is analysis"); and (3.) prototypical therapy plans will be developed as a basis for estimating the target staffing requirements. On this basis, a target staffing estimate will be made for all professional groups. For the study, a total of 80 psychosomatic clinics from Germany will be randomly selected, belonging in equal parts to the groups of psychosomatic university clinics, psychosomatic specialist hospitals, and psychosomatic departments in somatic or in psychiatric hospitals. In addition, 20 day clinics are included. In these clinics, the structural framework conditions including staffing will be surveyed and the routine documentation of therapy units will be evaluated by cluster analysis in order to empirically validate the presumed treatment clusters and to describe the necessary staffing requirements. The empirical examination and validation of the platform model, including the four assumed treatment clusters, has the potential to positively influence care practice in the long term by adjusting staffing levels in psychosomatic clinics to actual care requirements.


Recruitment information / eligibility

Status Recruiting
Enrollment 5961
Est. completion date December 31, 2023
Est. primary completion date May 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria for Clinics: - belong to the predefined nationwide population of psychosomatic specialist clinics and departments - randomly selected for inclusion in the study, - the clinic management (head physician or comparable) agrees to participation in the study - possibility of electronic recording of the qualified therapy units for all treating professional groups. Inclusion Criteria for Patients: - patient treated in one of the selected clinics on the corresponding ward or day clinic - at least 18 years old Exclusion Criteria: - none

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention, purely observational
There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.

Locations

Country Name City State
Germany Simone University Jennissen Heidelberg Baden-Württemberg

Sponsors (6)

Lead Sponsor Collaborator
University Hospital Heidelberg Deutsches Krankenhausinstitut, DGKJP, DGPM, DGPPN, Forum für Gesundheitswirtschaft gGmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Administered Treatments units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists Week one of treatment: assessment of administered treatment units
Primary Administered Treatments units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists Week two of treatment: assessment of administered treatment units
Primary Administered Treatments units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists Week three of treatment: assessment of administered treatment units
Primary Administered Treatments units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists Week four of treatment: assessment of administered treatment units
Primary Administered Treatments units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists Week five of treatment: assessment of administered treatment units
Primary Administered Treatments units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists Week six of treatment: assessment of administered treatment units
Primary Administered Treatments units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists Week seven of treatment: assessment of administered treatment units
Primary Administered Treatments units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists Week eight of treatment: assessment of administered treatment units
Secondary HONOS - Health of the Nation Outcome Scales measure of severity of mental illness administered once per patient at week one of treatment
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02799810 - Psychosocial Evaluation Prior to Lung Transplantation N/A